Company intelligence / Profile preview

SiPhox Health

Burlington, Massachusetts, United Statessiphoxhealth.com ↗

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

SiPhox Health offers a commercial at-home blood testing kit covering over a dozen biomarkers. Their next-generation silicon photonic chip-based device—capable of multiplexed protein/hormone analysis—is in development and seeking FDA clearance. No clinical trial results as the product is diagnostic.

Therapeutic areas: OtherCardiovascular
Modalities: DeviceDiagnostic platform (optical biochip/silicon photonics)
Industry: Protein Biomarker Diagnostics

Partnerships

None publicly disclosed with major pharma/biotech companies as of June 2025.

Beyond the preview

Go deeper on SiPhox Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SiPhox Health.

Explore the full profile